Efficacy and Safety of Subcutaneous Belimumab in Anti –Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus

Arthritis&Rheumatology, EarlyView.

Source: Arthritis and Rheumatology - June 15, 2018 Category: Rheumatology Authors: A. Doria MD , W. Stohl MD, PhD , A. Schwarting MD, PhD , M. Okada MD , M. Scheinberg MD, PhD , R. van Vollenhoven MD, PhD , A. E. Hammer BS , J. Groark MD , D. Bass DO, FACR , N. L. Fox PhD , D. Roth MD , D. Gordon MB, ChB Source Type: research